Investment for health and wellbeing

Q2 2025 report published - read more

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Pareto Securities' Healthcare Conference

We are pleased to inform that Oriola will be attending Pareto Securities' Healthcare Conference in Stockholm on 16 September 2025 with CEO Katarina Gabrielson as a speaker.

Oriola's science-based climate targets

Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.

Half-Year Report 2025

Strong partnerships drive Distribution growth and profitability

Annual Report 2024

Growth through strategy implementation. Find out more about Oriola's year 2024.